logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

ZYLOXTB (02190) spent HKD 1.163 million on August 28 to repurchase 53,000 shares.

date
20:27 28/08/2026
avatar
GMT Eight
Guochuang Tongqiao (02190) announced that on August 28, 2026, the company spent HK$1.163 million to repurchase 53,000 shares.
ZYLOXTB (02190) announced that on August 28, 2026, the company spent HKD 1.163 million to repurchase 53,000 shares.
Related Articles
HK Stock
ABBISKO-B (02256) spent HKD 290,700 on August 28 to repurchase 30,000 shares.
HK Stock
CHINA WANTIAN (01854) announced its interim results, reporting a loss attributable to shareholders of HKD 29.01 million, a year-on-year decrease of 37.96%.
HK Stock
TOUYUN BIOTECH (01332) announced its interim performance, with a profit attributed to shareholders of approximately HKD 198 million, representing a year-on-year increase of about 16.6 times.
ABBISKO-B (02256) spent HKD 290,700 on August 28 to repurchase 30,000 shares.
HK Stock
CHINA WANTIAN (01854) announced its interim results, reporting a loss attributable to shareholders of HKD 29.01 million, a year-on-year decrease of 37.96%.
HK Stock
TOUYUN BIOTECH (01332) announced its interim performance, with a profit attributed to shareholders of approximately HKD 198 million, representing a year-on-year increase of about 16.6 times.
HK Stock
RECOMMEND
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
icon
10/06/2026
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
icon
10/06/2026
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
icon
10/06/2026
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.